Medopharm — Mebendazole Exporter Profile
Indian Pharmaceutical Exporter · #10 for Mebendazole · $220.3K export value · DGFT Verified
Medopharm is the #10 Indian exporter of Mebendazole with $220.3K in export value and 34 verified shipments. Medopharm holds a 1.6% market share in Mebendazole exports across 9 countries. The company exports 21 pharmaceutical products worth $50.2M across 10 therapeutic categories.
Medopharm — Mebendazole Export Profile: Buyers & Destinations
Where Does Medopharm Export Mebendazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $118.6K | 15 | 47.3% |
| UNITED ARAB EMIRATES | $53.9K | 10 | 21.5% |
| UNITED STATES | $30.3K | 3 | 12.1% |
| TANZANIA | $12.9K | 2 | 5.2% |
| MOZAMBIQUE | $12.0K | 2 | 4.8% |
| CONGO | $10.5K | 1 | 4.2% |
| YEMEN, DEMOCRATIC | $4.7K | 1 | 1.9% |
| FIJI | $4.4K | 1 | 1.7% |
| ISRAEL | $3.1K | 1 | 1.2% |
| SYRIA | $183 | 1 | 0.1% |
Medopharm exports Mebendazole to 10 countries. The largest destination is NETHERLANDS accounting for 47.3% of Medopharm's Mebendazole shipments, followed by UNITED ARAB EMIRATES (21.5%) and UNITED STATES (12.1%). These destinations reflect Medopharm's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Mebendazole from Medopharm?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S. IMRES | NETHERLANDS | $31.6K | 3 |
| BLESSINGS INTERNATIONAL | UNITED STATES | $30.3K | 3 |
| M S IMRES | NETHERLANDS | $27.0K | 1 |
| IDA TRADING MEAC/OKUEHNE+NAGEL LLC. | UNITED ARAB EMIRATES | $19.9K | 2 |
| THE MEDICAL EXPORT GROUP | NETHERLANDS | $18.3K | 2 |
| IMRES | NETHERLANDS | $13.6K | 3 |
| CAMEPS-CG ZONE INDUSTRIELLE M PILAB P | CONGO | $10.5K | 1 |
| M/S. AMSTEL FARMA BV | NETHERLANDS | $9.5K | 2 |
| IMPERIAL MEDICAL SOLUTIONS FZE | UNITED ARAB EMIRATES | $8.6K | 2 |
| IMPERIAL MEDICAL SOLUTIONS FZE. | UNITED ARAB EMIRATES | $6.7K | 1 |
Medopharm supplies Mebendazole to 25 buyers globally. The largest buyer is M/S. IMRES (NETHERLANDS), followed by BLESSINGS INTERNATIONAL (UNITED STATES) and M S IMRES (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Mebendazole Export Value and How Much Does Medopharm Contribute?
India exported $7.1M worth of Mebendazole through 2,932 shipments from 259 suppliers to 108 countries, serving 756 buyers globally. Medopharm contributes $220.3K to this total, accounting for 1.6% of India's Mebendazole exports. Medopharm ships Mebendazole to 10 countries through 25 buyers.
What Is the Average Shipment Value for Medopharm's Mebendazole Exports?
Medopharm's average Mebendazole shipment value is $6.5K per consignment, based on 34 shipments totaling $220.3K. The largest destination is NETHERLANDS (47.3% of Medopharm's Mebendazole exports).
How Does Medopharm Compare to Other Indian Mebendazole Exporters?
Medopharm ranks #10 among 259 Indian Mebendazole exporters with a 1.6% market share. The top 3 exporters are CADILA PHARMACEUTICALS LIMITED ($2.7M), LINCOLN PHARMACEUTICALS LTD ($1.1M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($539.7K). Medopharm processed 34 shipments to 9 destination countries.
What Mebendazole Formulations Does Medopharm Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MEBENDAZOLE TABLETS USP 100MG (2000 X 10 | $27.4K | 2 |
| MEBENDAZOLE TABLETS USP 100MG 4000 X 1000 JAR | $27.0K | 1 |
| MEBENDAZOLE TABLETS USP 100MG (10000 X 10 X 10) - BOX | $26.4K | 3 |
| MEBENDAZOLE TABLETS USP 100MG (1000 X 10 | $15.7K | 3 |
| MEBENDAZOLE TABLETS USP 100MG (2000 X 1000) - JAR | $15.1K | 1 |
| MEBENDAZOLE TABLETS USP 100MG 1000 X 1000 JAR | $13.2K | 2 |
| MEBENDAZOLE TABLETS USP 100MG (1000 X 1000) - JARNOS | $13.2K | 2 |
| MEBENDAZOLE TABLETS USP 500MG 1000 X 500 - JAR | $11.9K | 1 |
| MEBENDAZOLE TABLETS USP 100MG 10000 X 10 X 10 - BOX | $10.5K | 1 |
| MEBENDAZOLE TABLETS USP 100MG (5000 X 10 | $9.0K | 2 |
Medopharm exports 29 distinct Mebendazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEBENDAZOLE TABLETS USP 100MG (2000 X 10 with 2 shipments worth $27.4K.
Regulatory Requirements: Exporting Mebendazole to Key Markets
What Medopharm must comply with to export Mebendazole to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Medopharm Compare to Nearest Mebendazole Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | $256.0K | 18 | 5 | $14.2K |
| 9 | CADILA PHARMACEUTICALS LTD | $233.7K | 5 | 2 | $46.7K |
| 10 | MEDOPHARM ★ | $220.3K | 34 | 9 | $6.5K |
| 11 | ZIM LABORATORIES LIMITED. | $197.3K | 4 | 1 | $49.3K |
| 12 | RONAK EXIM PRIVATE LTD | $188.4K | 45 | 4 | $4.2K |
Medopharm ranks #10 among 259 Indian Mebendazole exporters. Average shipment value of $6.5K compared to the market average of $27.3K. The closest competitors by value are FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED and CADILA PHARMACEUTICALS LTD.
Which Indian Ports Ship Mebendazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 513 | 17.5% |
| SAHAR AIR | 450 | 15.3% |
| NHAVA SHEVA SEA (INNSA1) | 300 | 10.2% |
| DELHI AIR CARGO ACC (INDEL4) | 289 | 9.9% |
| JNPT/ NHAVA SHEVA SEA | 170 | 5.8% |
| DELHI AIR | 162 | 5.5% |
| JNPT | 130 | 4.4% |
| AHEMDABAD ICD | 96 | 3.3% |
What Other Antimalarial & Antiparasitic Products Does Medopharm Export?
Medopharm also exports these antimalarial & antiparasitic products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medopharm's Mebendazole Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medopharm. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions have particularly impacted trade corridors through the Persian Gulf and the Strait of Hormuz, vital for India's drug shipments. (pharmaceuticalcommerce.com)
Conversely, US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of 100% tariffs on branded or patented pharmaceutical products by the US in October 2025 poses a significant challenge. While generic drugs may remain largely unaffected, companies like Medopharm must navigate these policy shifts carefully. (itisbl.com)
The recent India–European Union Free Trade Agreement, concluded in January 2026, offers a favorable development. The agreement eliminates tariffs on most European pharmaceutical exports to India and vice versa, potentially enhancing market access for Indian companies in the EU. (en.wikipedia.org)
Medopharm — Regulatory Compliance & Quality Standards
India's pharmaceutical industry has made significant strides in regulatory compliance, with the country surpassing the US in the number of FDA-registered generic manufacturing sites as of 2024. This achievement reflects improved adherence to international quality standards, a critical factor for exporters like Medopharm. (business-standard.com)
However, the industry faces challenges related to quality compliance, as evidenced by incidents involving contaminated products. Maintaining rigorous quality control measures is essential for sustaining global trust and market access. (economictimes.indiatimes.com)
About Medopharm
Medopharm exports 21 products worth $50.2M. Beyond Mebendazole, top products include Amoxicillin, Metronidazole, Paracetamol, Albendazole, Ciprofloxacin. View the complete Medopharm profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mebendazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Mebendazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medopharm matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 37 individual customs records matching Medopharm exporting Mebendazole, covering 29 formulations to 10 countries via 25 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 108+ countries, 756+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Mebendazole Export Data from Medopharm
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medopharm's Mebendazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medopharm
Full Company Profile →
21 products · $50.2M total trade · 10 categories
Mebendazole Stats
Company Overview
Top Products by Medopharm
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medopharm.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mebendazole. For current shipment-level data, contact TransData Nexus.